Reducing Doxorubicin resistance in breast cancer by liposomal FOXM1 aptamer: In vitro and in vivo
出版年份 2020 全文链接
标题
Reducing Doxorubicin resistance in breast cancer by liposomal FOXM1 aptamer: In vitro and in vivo
作者
关键词
FOXM1 aptamer, Liposomal formulation, Doxorubicin, Breast cancer, Doxorubicin resistance
出版物
LIFE SCIENCES
Volume 262, Issue -, Pages 118520
出版商
Elsevier BV
发表日期
2020-10-01
DOI
10.1016/j.lfs.2020.118520
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Tuning mPEG-PLA/vitamin E-TPGS-based mixed micelles for combined celecoxib/honokiol therapy for breast cancer
- (2020) Jiahui Sun et al. EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES
- Aptamer-functionalized liposomes for targeted cancer therapy
- (2019) Seyedeh Alia Moosavian et al. CANCER LETTERS
- A view on drug resistance in cancer
- (2019) Neil Vasan et al. NATURE
- Targeting forkhead box M1 transcription factor in breast cancer
- (2018) Ruth M. O'Regan et al. BIOCHEMICAL PHARMACOLOGY
- The challenge of drug resistance in cancer treatment: a current overview
- (2018) Michail Nikolaou et al. CLINICAL & EXPERIMENTAL METASTASIS
- Liposomal CpG-ODN: An in vitro and in vivo study on macrophage subtypes responses, biodistribution and subsequent therapeutic efficacy in mice models of cancers
- (2018) Sara Nikoofal-Sahlabadi et al. EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES
- The FOXO3-FOXM1 axis: A key cancer drug target and a modulator of cancer drug resistance
- (2018) Shang Yao et al. SEMINARS IN CANCER BIOLOGY
- Targeted delivery of doxorubicin to cancer cells by a cruciform DNA nanostructure composed of AS1411 and FOXM1 aptamers
- (2018) Khalil Abnous et al. Expert Opinion on Drug Delivery
- Suppression of FOXM1 Transcriptional Activities via a Single-Stranded DNA Aptamer Generated by SELEX
- (2017) Qin Xiang et al. Scientific Reports
- Coexpression of CAV-1, AT1-R and FOXM1 in prostate and breast cancer and normal cell lines and their influence on metastatic properties
- (2016) Karolina Kowalska et al. ACTA BIOCHIMICA POLONICA
- Prognostic significance of FOXM1 expression and antitumor effect of FOXM1 inhibition in synovial sarcomas
- (2016) Akira Maekawa et al. BMC CANCER
- FOXM1 regulates expression of eukaryotic elongation factor 2 kinase and promotes proliferation, invasion and tumorgenesis of human triple negative breast cancer cells
- (2016) Zuhal Hamurcu et al. Oncotarget
- FOXM1 targets XIAP and Survivin to modulate breast cancer survival and chemoresistance
- (2015) Gabriela Nestal de Moraes et al. CELLULAR SIGNALLING
- MicroRNA-802 suppresses breast cancer proliferation through downregulation of FoxM1
- (2015) FENG YUAN et al. Molecular Medicine Reports
- Smart doxorubicin nanoparticles with high drug payload for enhanced chemotherapy against drug resistance and cancer diagnosis
- (2015) Caitong Yu et al. Nanoscale
- Inhibition of Forkhead box protein M1 by thiostrepton increases chemosensitivity to doxorubicin in T-cell acute lymphoblastic leukemia
- (2015) JIAN-YONG WANG et al. Molecular Medicine Reports
- The Role of the Helper Lipid on the DNA Transfection Efficiency of Lipopolyplex Formulations
- (2014) Zixiu Du et al. Scientific Reports
- Drug Resistance in Cancer: An Overview
- (2014) Genevieve Housman et al. Cancers
- Nanomedicine therapeutic approaches to overcome cancer drug resistance
- (2013) Janet L. Markman et al. ADVANCED DRUG DELIVERY REVIEWS
- CCL5 as a potential immunotherapeutic target in triple-negative breast cancer
- (2013) Dandan Lv et al. Cellular & Molecular Immunology
- Novel methods for liposome preparation
- (2013) Yogita P. Patil et al. CHEMISTRY AND PHYSICS OF LIPIDS
- SUMOylation inhibits FOXM1 activity and delays mitotic transition
- (2013) S S Myatt et al. ONCOGENE
- FOXM1 mediates Dox resistance in breast cancer by enhancing DNA repair
- (2012) Yun-Yong Park et al. CARCINOGENESIS
- Suppression of FOXM1 Sensitizes Human Cancer Cells to Cell Death Induced by DNA-Damage
- (2012) Marianna Halasi et al. PLoS One
- Role of the forkhead transcription factor FOXO-FOXM1 axis in cancer and drug resistance
- (2012) Fung Zhao et al. Frontiers of Medicine
- FOXM1 Confers Acquired Cisplatin Resistance in Breast Cancer Cells
- (2010) J. M.-M. Kwok et al. MOLECULAR CANCER RESEARCH
- Triple-negative breast cancer: disease entity or title of convenience?
- (2010) Lisa Carey et al. Nature Reviews Clinical Oncology
- Doxorubicin pathways
- (2010) Caroline F. Thorn et al. Pharmacogenetics and Genomics
- Lipid-based delivery of CpG oligonucleotides enhances immunotherapeutic efficacy
- (2009) Kaley D. Wilson et al. ADVANCED DRUG DELIVERY REVIEWS
- Cytotoxicity, intracellular distribution and uptake of doxorubicin and doxorubicin coupled to cell-penetrating peptides in different cell lines: A comparative study
- (2009) Sonia Aroui et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Nanoparticles evading the reticuloendothelial system: Role of the supported bilayer
- (2009) Shyh-Dar Li et al. BIOCHIMICA ET BIOPHYSICA ACTA-BIOMEMBRANES
- Triple negative breast cancers: Clinical and prognostic implications
- (2009) S.J. Dawson et al. EUROPEAN JOURNAL OF CANCER
- Thiazole Antibiotics Target FoxM1 and Induce Apoptosis in Human Cancer Cells
- (2009) Uppoor G. Bhat et al. PLoS One
- Liposomes and nanoparticles: nanosized vehicles for drug delivery in cancer
- (2009) Yogeshkumar Malam et al. TRENDS IN PHARMACOLOGICAL SCIENCES
- Tight correlation between expression of the Forkhead transcription factor FOXM1 and HER2 in human breast cancer
- (2008) Nuran Bektas et al. BMC CANCER
- A Phase II Study of Capecitabine and Vinorelbine in Patients with Metastatic Breast Cancer Pretreated with Anthracyclines and Taxanes
- (2008) Laura G. Estévez et al. Clinical Breast Cancer
- Sterol-Modified Phospholipids: Cholesterol and Phospholipid Chimeras with Improved Biomembrane Properties
- (2008) Zhaohua Huang et al. JOURNAL OF THE AMERICAN CHEMICAL SOCIETY
- Thiostrepton selectively targets breast cancer cells through inhibition of forkhead box M1 expression
- (2008) J. M-M. Kwok et al. MOLECULAR CANCER THERAPEUTICS
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started